Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-modal Assessment of GABA Function in Psychosis
NCT04004416Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Jan 2020
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorazepam in psychosis, schizophrenia, schizoaffective disorder, bipolar disorder (BD), sponsored by University of Michigan. Started Jan 2020; status: completed.
02
Drugs
lorazepam
03
Conditions
psychosisschizophreniaschizoaffective disorderbipolar disorder (BD)
Beyond the preview
Go deeper on NCT04004416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04004416.